Skip to main content
Equibles

MORGAN STANLEY

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,068,637
+$3,359,681 QoQ
Shares Held
2,743,499
+25.5% QoQ
Ownership
0.512%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 72% Shared 0% None 28%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. RXRX ranks #138 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in RXRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,068,637 2,743,499
2026-03-31 $6,708,956 2,185,329
2025-12-31 $23,139,490 5,657,578
2025-09-30 $35,576,918 7,290,353
2025-06-30 $28,789,432 5,689,612
2025-03-31 $26,505,187 5,010,433
2024-12-31 $19,337,159 2,860,527
2024-09-30 $12,370,749 1,877,201
2024-06-30 $13,262,336 1,768,312
2024-03-31 $19,578,852 1,963,777
2023-12-31 $25,398,360 2,575,899
2023-09-30 $6,170,655 806,622
2023-06-30 $2,915,007 390,229
2023-03-31 $1,729,974 259,367
2022-12-31 $2,568,745 333,171
2022-09-30 $2,936,020 275,942
2022-06-30 $1,804,667 221,704
2022-03-31 $1,006,672 140,597
2021-12-31 $1,978,530 115,501
2021-09-30 $223,196 9,700
2021-06-30 $41,463 1,136